OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GNGR57

Ginegar Plastic Products Ltd

Commodity ChemicalsVerified

Ginegar's capital structure is characterized by a debt-to-equity ratio of 1.65, indicating a moderate reliance on debt financing. The company holds 84.28 million ILS in cash and equivalents, but this is offset by long-term debt of 317.48 million ILS, resulting in a net cash position that is negative after subtracting total debt. The current ratio of 1.46 suggests the company has sufficient short-term assets to cover its short-term liabilities, but the negative operating and free cash flows of -17.41 million ILS and -17.26 million ILS, respectively, highlight liquidity constraints. Profitability metrics show a return on equity of 2.44% and a return on assets of 0.7%, both below the typical thresholds for healthy performance in the Commodity Chemicals industry. The operating margin of 3.8% and net margin of 0.75% are weak, indicating that the company is struggling to convert revenue into profit. These figures are likely influenced by high production costs and competitive pricing pressures in the plastics and agricultural films market. The company's revenue is concentrated in a few key markets, with Israel, Europe, and North America being the primary regions for sales. However, the financial snapshot does not provide a breakdown of revenue by segment or geography, making it difficult to assess the extent of regional concentration risk. The lack of detailed segment reporting limits the ability to evaluate the performance of different product lines or geographic markets. Ginegar's growth trajectory is uncertain, as the financial data does not include forward-looking revenue projections or historical growth rates. The negative operating and free cash flows suggest that the company may be investing in capital expenditures to support future growth, as evidenced by the capital expenditure of -32.22 million ILS. However, without clear guidance on the expected return on these investments, it is difficult to assess the company's long-term growth potential. The risk assessment highlights liquidity as a medium concern, with the company's negative net cash position and negative operating cash flow indicating potential challenges in maintaining short-term solvency. The dilution risk is assessed as low, but the company's reliance on debt financing could increase financial leverage and expose it to interest rate risk. The absence of detailed information on recent equity issuances or share buybacks limits the ability to assess dilution potential. Recent events and filings are not detailed in the provided data, but the company's financial performance and capital structure suggest that it may be facing operational and financial challenges. The negative cash flows and high debt levels could lead to increased scrutiny from investors and creditors, particularly if the company is unable to improve its profitability or secure additional financing.

30-day price · GNGR-126.70 (-16.8%)
Low$623.60High$753.70Close$627.00As of17 May, 00:00 UTC
Profile
CompanyGinegar Plastic Products Ltd
TickerGNGR.TA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Ginegar Plastic Products Ltd develops and produces greenhouse cover films and mulch films for open field cultivation, with applications in soil protection, fumigation, and chemical fertilizer bags, marketed in Israel, Europe, and North America through its subsidiaries.

Classification. Ginegar is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Ginegar's capital structure is characterized by a debt-to-equity ratio of 1.65, indicating a moderate reliance on debt financing. The company holds 84.28 million ILS in cash and equivalents, but this is offset by long-term debt of 317.48 million ILS, resulting in a net cash position that is negative after subtracting total debt. The current ratio of 1.46 suggests the company has sufficient short-term assets to cover its short-term liabilities, but the negative operating and free cash flows of -17.41 million ILS and -17.26 million ILS, respectively, highlight liquidity constraints. Profitability metrics show a return on equity of 2.44% and a return on assets of 0.7%, both below the typical thresholds for healthy performance in the Commodity Chemicals industry. The operating margin of 3.8% and net margin of 0.75% are weak, indicating that the company is struggling to convert revenue into profit. These figures are likely influenced by high production costs and competitive pricing pressures in the plastics and agricultural films market. The company's revenue is concentrated in a few key markets, with Israel, Europe, and North America being the primary regions for sales. However, the financial snapshot does not provide a breakdown of revenue by segment or geography, making it difficult to assess the extent of regional concentration risk. The lack of detailed segment reporting limits the ability to evaluate the performance of different product lines or geographic markets. Ginegar's growth trajectory is uncertain, as the financial data does not include forward-looking revenue projections or historical growth rates. The negative operating and free cash flows suggest that the company may be investing in capital expenditures to support future growth, as evidenced by the capital expenditure of -32.22 million ILS. However, without clear guidance on the expected return on these investments, it is difficult to assess the company's long-term growth potential. The risk assessment highlights liquidity as a medium concern, with the company's negative net cash position and negative operating cash flow indicating potential challenges in maintaining short-term solvency. The dilution risk is assessed as low, but the company's reliance on debt financing could increase financial leverage and expose it to interest rate risk. The absence of detailed information on recent equity issuances or share buybacks limits the ability to assess dilution potential. Recent events and filings are not detailed in the provided data, but the company's financial performance and capital structure suggest that it may be facing operational and financial challenges. The negative cash flows and high debt levels could lead to increased scrutiny from investors and creditors, particularly if the company is unable to improve its profitability or secure additional financing.
Key takeaways
  • Ginegar has a high debt-to-equity ratio of 1.65, indicating a significant reliance on debt financing.
  • The company's return on equity of 2.44% and return on assets of 0.7% are below industry norms, suggesting weak profitability.
  • Operating and free cash flows are negative, highlighting liquidity constraints and potential solvency risks.
  • The company's revenue is concentrated in a few key markets, but detailed segment reporting is lacking.
  • Capital expenditures of -32.22 million ILS suggest investment in future growth, but the expected return is unclear.
  • The risk assessment indicates medium liquidity risk and low dilution risk, but the company's financial leverage could increase interest rate exposure.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyILS
Revenue$628.3M
Gross profit$113.2M
Operating income$23.8M
Net income$4.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$17.4M
CapEx-$32.2M
Free cash flow-$17.3M
Total assets$671.2M
Total liabilities$478.2M
Total equity$192.9M
Cash & equivalents$84.3M
Long-term debt$317.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$192.9M
Net cash-$233.2M
Current ratio1.5
Debt/Equity1.6
ROA0.7%
ROE2.4%
Cash conversion-3.7%
CapEx/Revenue-5.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricGNGRActivity
Op margin3.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin0.7%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin18.0%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-5.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity165.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 18:18 UTC#a8e0dd8e
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 13:28 UTCJob: 17465d85